Affiliation:
1. Department of Endocrinology and Metabolism, Institute of Endocrinology, National Health Commission Key Laboratory of Diagnosis and Treatment of Thyroid Diseases, The First Hospital of China Medical University , Shenyang 110001, Liaoning , P. R. China
2. Department of Endocrinology, Shengjing Hospital of China Medical University , Shenyang 110004, Liaoning , P. R. China
Abstract
Abstract
Context
Subclinical hypothyroidism is associated with metabolic diseases; however, it remains controversial in older individuals.
Objective
This work aimed to investigate the relationship between thyrotropin (TSH) levels and metabolic diseases.
Methods
In this cross-sectional study, sampling was conducted from nationally representative general communities from 31 provinces in mainland China. A total of
6791 older (aged ≥65 years) and 55 303 young participants (aged 18-64 years) were selected after excluding individuals with overt hyperthyroidism or overt hypothyroidism. According to the kit, TSH reference range (0.27-4.2 mU/L) and the age-specific TSH range previously formulated (an upper limit of 8.86 mU/L for older adults and 6.57 mU/L for young adults), the older adults and young adults were separately divided into 4 groups based on their TSH levels. Main outcome measures included anthropometric assessments, serum concentrations of thyroid functions, and various metabolic parameters.
Results
In contrast to young adults, there was no significant increase in the prevalence of any metabolic disorders assessed in the slightly elevated TSH group (TSH 4.21-8.86 mU/L) compared to the euthyroid group (TSH 0.27-4.2 mU/L) among older adults. After adjusting for interference factors, a TSH level higher than 8.86 mU/L was found to be an independent risk factor for low high-density lipoprotein cholesterol (OR, 1.84; 95% CI, 1.14-2.98) and dyslipidemia (OR, 1.49; 95% CI, 1.09-2.04) when compared to the euthyroid group in older adults.
Conclusion
Slightly elevated TSH levels are not associated with an increased risk of metabolic diseases in older adults. Therefore, we recommend raising the upper limit of the TSH range for individuals aged 65 years and older.
Funder
Public Welfare, National Health and Family Planning Commission of China
National Natural Science Foundation of China
National Key Technologies R&D Program
Ministry of Science and Technology
People’s Republic of China